Daxor’s Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026
Daxor Corporation announced new clinical data presented at SCCM 2026 showing its Blood Volume Analyzer (BVA) uniquely and accurately measures albumin escape rate, outperforming traditional clinical capillary leak indices in heart failure patients. This reinforces Daxor's position as the sole provider of direct, real-time blood volume and leak measu…